Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Targeting CD20: teaching an old dog new tricks

Jeff P. Sharman

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 273–278.

https://doi.org/10.1182/hematology.2019000031

Published: 2019

Journal Articles

Where to start? Upfront therapy for follicular lymphoma in 2018

John P. Leonard, Loretta J. Nastoupil, Christopher R. Flowers

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 185–188.

https://doi.org/10.1182/asheducation-2018.1.185

Published: 2018

Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.

https://doi.org/10.1182/asheducation-2018.1.9

Published: 2018

Journal Articles

Current treatment of double hit and double expressor lymphoma

Patrick M. Reagan, Andrew Davies

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 295–297.

https://doi.org/10.1182/asheducation-2017.1.295

Published: 2017

Journal Articles

Novel agents in follicular lymphoma: choosing the best target

Laurie H. Sehn

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 284–292.

https://doi.org/10.1182/asheducation-2016.1.284

Published: 2016

Journal Articles

The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia

Daniel J. DeAngelo

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 400–405.

https://doi.org/10.1182/asheducation-2015.1.400

Published: 2015

Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.

https://doi.org/10.1182/asheducation-2015.1.368

Published: 2015

Journal Articles

Advances in therapies for non-Hodgkin lymphoma in children

Rachel Kobos, William Terry

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 522–528.

https://doi.org/10.1182/asheducation.V2015.1.522.3916185

Published: 2015

Journal Articles

Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

Michelle Fanale

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 406–413.

https://doi.org/10.1182/asheducation-2013.1.406

Published: 2013

Journal Articles

Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies

James T. B. Crawley, Marie A. Scully

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 292–299.

https://doi.org/10.1182/asheducation-2013.1.292

Published: 2013

Journal Articles

Novel Antibody-Based Therapies For Acute Lymphoblastic Leukemia

Dieter Hoelzer

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 243–249.

https://doi.org/10.1182/asheducation-2011.1.243

Published: 2011

Journal Articles

Novel Agents for Follicular Lymphoma

John P. Leonard, Peter Martin

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 259–264.

https://doi.org/10.1182/asheducation-2010.1.259

Published: 2010

Journal Articles

Evidence-Based Mini-Review: The Role of Alkylating Agents in the Initial Treatment of Chronic Lymphocytic Leukemia Patients with the 11q Deletion

Wei Ding, Alessandra Ferrajoli

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 90–92.

https://doi.org/10.1182/asheducation-2010.1.90

Published: 2010

Journal Articles

State-of-the-art treatment of chronic lymphocytic leukemia

Michael Hallek

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 440–449.

https://doi.org/10.1182/asheducation-2009.1.440

Published: 2009

Journal Articles

Antibody Therapy in Aggressive Lymphomas

Thomas M. Habermann

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 257–264.

https://doi.org/10.1182/asheducation-2007.1.257

Published: 2007

Journal Articles

Follicular NHL: From Antibodies and Vaccines to Graft-versus-Lymphoma Effects

David G. Maloney

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 226–232.

https://doi.org/10.1182/asheducation-2007.1.226

Published: 2007

Journal Articles

Monoclonal Antibodies for B-Cell Lymphomas: Rituximab and Beyond

Celeste Bello, Eduardo M. Sotomayor

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 233–242.

https://doi.org/10.1182/asheducation-2007.1.233

Published: 2007

Journal Articles

Targeting CD20 in Follicular NHL: Novel Anti-CD20 Therapies, Antibody Engineering, and the Use of Radioimmunoconjugates

John P. Leonard

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 335–339.

https://doi.org/10.1182/asheducation-2005.1.335

Published: 2005

Journal Articles

Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody Therapy

Jonathan W. Friedberg

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 329–334.

https://doi.org/10.1182/asheducation-2005.1.329

Published: 2005

Journal Articles

Update on Epidemiology and Therapeutics for Non-Hodgkin’s Lymphoma

Julie M. Vose, Brian C.-H. Chiu, Bruce D. Cheson, Janet Dancey, John Wright

Hematology Am Soc Hematol Educ Program (2002) 2002 (1): 241–262.

https://doi.org/10.1182/asheducation-2002.1.241

Published: 2002

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Targeting CD20: teaching an old dog new tricks

Where to start? Upfront therapy for follicular lymphoma in 2018

Antibody-based therapies in patients with acute lymphoblastic leukemia

Current treatment of double hit and double expressor lymphoma

Novel agents in follicular lymphoma: choosing the best target

The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia

Prognostic markers and standard management of chronic lymphocytic leukemia

Advances in therapies for non-Hodgkin lymphoma in children

Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies

Novel Antibody-Based Therapies For Acute Lymphoblastic Leukemia

Novel Agents for Follicular Lymphoma

Evidence-Based Mini-Review: The Role of Alkylating Agents in the Initial Treatment of Chronic Lymphocytic Leukemia Patients with the 11q Deletion

State-of-the-art treatment of chronic lymphocytic leukemia

Antibody Therapy in Aggressive Lymphomas

Follicular NHL: From Antibodies and Vaccines to Graft-versus-Lymphoma Effects

Monoclonal Antibodies for B-Cell Lymphomas: Rituximab and Beyond

Targeting CD20 in Follicular NHL: Novel Anti-CD20 Therapies, Antibody Engineering, and the Use of Radioimmunoconjugates

Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody Therapy

Update on Epidemiology and Therapeutics for Non-Hodgkin’s Lymphoma

ASH Publications

American Society of Hematology